HMO-SYNTHESE

Patent europeic · EP2440661 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2440661
Numer da la dumonda
EP09776698
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
08-06-2009
Publitgà
18-04-2012
Concedì
06-12-2017
Stritgà
10-01-2024
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
C12N 1/00 (2006.01)
C12N 15/63 (2006.01)
C12P 19/00 (2006.01)
C12P 19/18 (2006.01)
C12N 9/10 (2006.01)
C12N 15/70 (2006.01)
Dumonda PCT
PCT/EP2009/004112 08.06.2009
Publicaziun PCT
WO2010/142305 16.12.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 10-01-2024

    Midada

    Published in Swissreg on 10.01.2024

  2. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  3. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  4. 23-06-2021

    Adressa midada

    Owner
    Jennewein Biotechnologie GmbH, Maarweg 32, 53619 Rheinbreitbach, Germany → Chr. Hansen HMO GmbH, Maarweg 32, 53619 Rheinbreitbach, Germany

    Published in Swissreg on 23.06.2021

  5. 06-12-2017

    Concedì

    Published in Swissreg on 06.12.2017

Partidas

Possessur

Chr. Hansen HMO GmbH

Maarweg 32, 53619 Rheinbreitbach, DE

Inventur

JENNEWEIN, Stefan

53619 Rheinbreitbach, DE

HÜFNER, Eric

53773 Hennef, DE

PARKOT, Julia

51143 Köln, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.